Highly Attractive
Savings
on $, € & ¥ Costs |
| |
| |
Exceptionally Efficient Regulatory Interface |
Substantially Enhanced |
Enrolment Rate |
Highly Responsive Interface |
| |
| |
| |
Excellent Familiarity
with Indian Environment
Study Specific Infrastructure
Investments
India Specific
GCP Compliant SOPs
Effective Support for Sites &
Investigators |
| |
Convenient EST/UTC morning and Tokyo forenoon teleconferences |
|
| |
|
| |
|
| |
| |
Apothecaries Client Base
Global Blue-chip, Midsized as well as Emerging Pharmaceutical Sponsors based at USA, Europe, Japan, Canada, Australia, Singapore and India |
|
| |
|
| |
|
| |
| |
| for |
| • |
Phase I-IV studies |
| • |
Pediatric studies |
| • |
Regulatory affairs |
| • |
Monitoring & Audits |
| • |
Site Management Services |
| • |
PK, PD, BA, BE studies |
|
|
|
| |
| |
| |
Therapeutic Categories' Experiences |
| |
| • |
Oncology |
• |
Gynaecology |
| • |
Tuberculosis |
• |
Pain Management |
| • |
Dermatology (and VD) |
• |
Organ Transplant |
| • |
Respiratory System (including Asthma, COPD) |
• |
Vaccines |
| • |
Cardiology (including CHF, MI, Dyslipidemia) |
• |
Orthopedics |
| • |
Psychiatry |
• |
Dentistry |
| • |
Genito-Urinary System |
• |
Haematology |
| • |
Endocrinology (including Diabetes) |
• |
Surgery |
| • |
Nervous System (including CNS, PNS, Stroke) |
• |
Medical Devices |
| • |
Pediatrics |
• |
Infectious diseases (bacterial, viral & others) |
| • |
Gastro-Intestinal System |
• |
Topical and Inhalation safety & Tolerability studies |
|
| |
|
|
| |
|
|
|
|
|
